産婦人科学

Medicine & Life Sciences

1. Pre-Eclampsia 100%
2. Pregnancy 94%
3. Japan 74%
4. Uterine Cervical Neoplasms 61%
5. Placenta 56%
6. Endometrial Neoplasms 52%
7. Mothers 50%
8. Neoplasms 45%
9. Obstetrics 40%
10. Uterine Neoplasms 39%
11. Trachelectomy 37%
12. Multicenter Studies 35%
13. Cervical Intraepithelial Neoplasia 35%
14. Ovarian Neoplasms 34%
15. Fetal Growth Retardation 33%
16. Genes 32%
17. Indoleamine-Pyrrole 2,3,-Dioxygenase 27%
18. Cervix Mucus 26%
19. Fallopian Tubes 25%
20. Retrospective Studies 25%
21. Gynecology 24%
22. Noninvasive Prenatal Testing 24%
23. Trophoblasts 23%
24. Ovary 23%
25. Pregnant Women 22%
26. Paclitaxel 21%
27. Cervix Uteri 20%
28. Conization 20%
29. Congenital Diaphragmatic Hernias 19%
30. Carboplatin 19%
31. Drug Therapy 19%
32. Sizofiran 18%
33. nedaplatin 18%
34. Laparoscopy 18%
35. Cyclooxygenase 2 Inhibitors 18%
36. Serum 17%
37. Adenocarcinoma 17%
38. Genetic Testing 16%
39. Breast Neoplasms 16%
40. Postpartum Period 16%
41. Proteins 16%
42. Extremely Premature Infants 16%
43. Nectins 16%
44. Therapeutics 15%
45. Vaginal Neoplasms 15%
46. Hysterectomy 15%
47. Cell-Free Nucleic Acids 15%
48. Neoplasm Metastasis 14%
49. Genotype 14%
50. liposomal doxorubicin 14%
51. High-Throughput Nucleotide Sequencing 14%
52. Body Mass Index 14%
53. Female Infertility 14%
54. Recurrence 14%
55. Etodolac 14%
56. Endometrioid Carcinoma 14%
57. Assisted Reproductive Techniques 14%
58. Genetic Counseling 13%
59. Lymph Node Excision 13%
60. Postpartum Depression 13%
61. MicroRNAs 12%
62. Premature Birth 12%
63. Everolimus 12%
64. Squamous Intraepithelial Lesions 12%
65. Platinum 12%
66. Mutation 12%
67. Messenger RNA 12%
68. Laparotomy 12%
69. Estrogens 12%
70. Up-Regulation 12%
71. Infertility 12%
72. Pregnancy Rate 11%
73. DNA Repair 11%
74. Parturition 11%
75. Ovarian Epithelial Carcinoma 11%
76. Synaptonemal Complex 11%
77. Machine Learning 11%
78. Minimally Invasive Surgical Procedures 11%
79. Annexin A5 11%
80. Spontaneous Abortion 11%
81. Bevacizumab 11%
82. Immunohistochemistry 11%
83. Ultrasonography 11%
84. Premature Infants 10%
85. Cyclooxygenase 2 10%
86. Aneuploidy 10%
87. Prospective Studies 10%
88. Uterine Myomectomy 10%
89. Protein Phosphatase 2 10%
90. nitrofen 10%
91. Polymerase Chain Reaction 10%
92. Haplotypes 10%
93. Survival 10%
94. Blood Pressure 10%
95. Adjuvant Chemotherapy 9%
96. Biomarkers 9%
97. Clear Cell Adenocarcinoma 9%
98. Cytokines 9%
99. Follistatin-Related Proteins 9%
100. Lymph Nodes 9%